WVE logo

WVE
Wave Life Sciences Ltd

3,343
Mkt Cap
$2.34B
Volume
630,119.00
52W High
$21.73
52W Low
$5.28
PE Ratio
-10.24
WVE Fundamentals
Price
$12.32
Prev Close
$12.41
Open
$12.47
50D MA
$13.69
Beta
1.35
Avg. Volume
2.64M
EPS (Annual)
-$1.21
P/B
4.49
Rev/Employee
$134,785.49
$2,290.62
Loading...
Loading...
News
all
press releases
Cinctive Capital Management LP Lowers Holdings in WAVE Life Sciences Ltd. $WVE
Cinctive Capital Management LP decreased its holdings in shares of WAVE Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 60.2% in the 3rd quarter, according to the company in its most recent Form 13F...
MarketBeat·7h ago
News Placeholder
More News
News Placeholder
WAVE Life Sciences Ltd. (NASDAQ:WVE) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of WAVE Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) have received an average rating of "Moderate Buy" from the fourteen brokerages that are covering the stock, Marketbeat Ratings...
MarketBeat·4d ago
News Placeholder
WAVE Life Sciences (NASDAQ:WVE) Given New $52.00 Price Target at Canaccord Genuity Group
Canaccord Genuity Group raised their price objective on shares of WAVE Life Sciences from $43.00 to $52.00 and gave the company a "buy" rating in a research note on Tuesday...
MarketBeat·7d ago
News Placeholder
Wedbush Forecasts Strong Price Appreciation for WAVE Life Sciences (NASDAQ:WVE) Stock
Wedbush raised their price target on shares of WAVE Life Sciences from $33.00 to $35.00 and gave the stock an "outperform" rating in a research report on Friday...
MarketBeat·11d ago
News Placeholder
FY2029 Earnings Forecast for WVE Issued By HC Wainwright
WAVE Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Equities researchers at HC Wainwright lowered their FY2029 EPS estimates for WAVE Life Sciences in a research note issued to investors on Monday...
MarketBeat·13d ago
News Placeholder
HC Wainwright Reiterates "Buy" Rating for WAVE Life Sciences (NASDAQ:WVE)
HC Wainwright reiterated a "buy" rating and set a $30.00 price objective on shares of WAVE Life Sciences in a research note on Monday...
MarketBeat·15d ago
News Placeholder
Wave Life Sciences Teases Near-Term Obesity and RNA Editing Data as INLIGHT Readouts Near
Wave Life Sciences (NASDAQ:WVE) highlighted upcoming clinical catalysts across its obesity and RNA editing programs during a discussion hosted by Oppenheimer biotech analyst Cheng Li following the...
MarketBeat·15d ago
News Placeholder
Artisan Partners Limited Partnership Trims Stake in WAVE Life Sciences Ltd. $WVE
Artisan Partners Limited Partnership lessened its position in WAVE Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 45.6% in the 3rd quarter, according to its most recent 13F filing with the...
MarketBeat·16d ago
News Placeholder
WAVE Life Sciences (NASDAQ:WVE) Insider Sells $499,569.70 in Stock
WAVE Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) insider Chris Francis sold 33,194 shares of WAVE Life Sciences stock in a transaction dated Thursday, February 26th. The stock was sold at an...
MarketBeat·17d ago
News Placeholder
Primecap Management Co. CA Has $13.90 Million Position in WAVE Life Sciences Ltd. $WVE
Primecap Management Co. CA lessened its stake in WAVE Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 23.0% during the 3rd quarter, according to the company in its most recent 13F filing with the...
MarketBeat·17d ago
<
1
2
...
>

Latest WVE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.